David Illingsworth is leaving the corner office at Smith & Nephew plc (NYSE:SNN), the company announced today as part of its fourth-quarter earnings release.
Illingsworth, who is retiring after a nine-year tenure at the helm of the British orthopedics giant, will be replaced by Olivier Bohuon, whom the company poached from French pharmaceuticals firm Pierre Fabre. Bouhon also ran the pharmaceutical business of Abbott Laboratories. The transition, which has been in the works for months, is set to take place April 14.